•  
  •  
  •  
  •  

2026-07-22 03:01:52

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • CRISIL Limited Reports Q2 CY26 / Q1 FY27 Results: Consolidated Revenue Jumps 27.6% YoY to ₹1,075.39 Crore; Net Profit Reaches ₹216.46 Crore
  • Purple Finance Grants In-Principle Approval to Acquire 100% Stake in Saksham Gram Credit
  • InfoBeans Technologies Reports Q1 FY27 Results: Revenue Jumps 36.6% YoY to ₹152.77 Crore; Net Profit Stands at ₹21.62 Crore
  • Gamco Limited Reports Q1 FY27 Results: Consolidated Revenue Surges 105.8% YoY to ₹113.72 Crore; PAT Reaches ₹32.43 Crore
  • Gabriel India Reports Q1 FY27 Results: Consolidated Revenue Up 15.5% YoY to ₹1,425.68 Crore; Net Profit Reaches ₹108.13 Crore

Keywords Selected:  Unit4

Stock Report

  • NHPC declares CoD of Unit 4 of Subansiri Lower HE Project
  • Completion of US-FDA Inspection at Unit-IV, Tarapur of Aarti Pharmalabs Limited
  • Unit-IV of APL Healthcare Ltd classified as VAI by the US FDA
  • APL Healthcare Ltd's Unit-4 gets 5 observations from USFDA
  • Shilpa Medicare Ltd receives 8 observations from USFDA for Unit 4 at Jadcherla
  • Unimech Aerospace commissions two new manufacturing facilities at Bengaluru, KIADB Park
  • Kronox Lab Sciences Ltd receives statutory approvals for Unit 4 at Dahej
  • Fire Incident at APL Healthcare Ltd's Unit 4 at Naidupeta
  • Laurus Labs Limited receives EIR for API facility Unit-4
  • NHPC Ltd completes trial run of Unit 4 of Parbati-II HE project
  • Europe GMP Approval of Shilpa Medicare Ltd. Unit 4, Jadcherla, Telangana.
  • APL Healthcare Ltd updates on inspection
  • Shilpa Medicare Ltd updates on Europe GMP inspection at Unit 4, Jadcherla, Telangana
  • Aurobindo Pharma Ltd receives EIR from USFDA classifying Unit IV as 'Voluntary Action Indicated'
  • Shilpa Medicare Ltd, Unit IV, Jadcherla, Telangana has cleared TGA, Australia GMP inspection
  • Shilpa Medicare Ltd's Unit IV, Jadcherla, Telangana facility has received Health Canada GMP Approval
  • NTPC Ltd commissions Unit 4 of Nabinagar Thermal Power Project
  • Heranba Industries commences Commercial Production at its new Unit-IV

Latest Post

  • CRISIL Limited Reports Q2 CY26 / Q1 FY27 Results: Consolidated Revenue Jumps 27.6% YoY to ₹1,075.39 Crore; Net Profit Reaches ₹216.46 Crore
  • Purple Finance Grants In-Principle Approval to Acquire 100% Stake in Saksham Gram Credit
  • InfoBeans Technologies Reports Q1 FY27 Results: Revenue Jumps 36.6% YoY to ₹152.77 Crore; Net Profit Stands at ₹21.62 Crore
  • Gamco Limited Reports Q1 FY27 Results: Consolidated Revenue Surges 105.8% YoY to ₹113.72 Crore; PAT Reaches ₹32.43 Crore
  • Gabriel India Reports Q1 FY27 Results: Consolidated Revenue Up 15.5% YoY to ₹1,425.68 Crore; Net Profit Reaches ₹108.13 Crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025